Arch Biopartners Berita Eulerpool

Arch Biopartners Eulerpool News

Arch Biopartners Berita Saham

Arch Biopartners diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Arch Biopartners kami rangkum di sini.

• 11 September ·

  Yahoo
  Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
• 5 Agustus ·

  Yahoo
  Arch Biopartners’ cilastatin enters Phase II trial for AKI prevention
• 2 Agustus ·

  Yahoo
  Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 Agustus ·

  GlobeNewswire
  Arch Biopartners? Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
• 2 Agustus ·

  Thefly.com
  Arch Biopartners announces cilastatin to participate in PONTIAC Phase II trial
• 30 Juli ·

  Yahoo
  Arch Biopartners Closes Non-Brokered Private Placement
• 29 Juli ·

  Yahoo
  Arch Biopartners Arranges Non-Brokered Private Placement
• 27 Juni ·

  Yahoo
  Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
• 18 Juni ·

  Yahoo
  Arch Biopartners Obtains University of Calgary Ethics Approval to Proceed with Phase II Trial
• 18 Juni ·

  Yahoo
  Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)